ArticleJournal of medicinal chemistry2024

Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.

Jeffrey Mowat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.